All Stories

  1. Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases

    Article • MedComm, June 2025, Wiley

    Dr MUZAFAR AHMAD MACHA

  2. Radiogenomics and Machine Learning Predict Oncogenic Signaling Pathways in Glioblastoma

    Article • November 2024, Springer Science + Business Media

    Dr MUZAFAR AHMAD MACHA

  3. CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond

    Article • Vaccines, November 2023, MDPI AG

    Dr MUZAFAR AHMAD MACHA

  4. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment

    Article • International Journal of Molecular Sciences, April 2021, MDPI AG

    Dr MUZAFAR AHMAD MACHA

  5. Therapeutic Effects of Curcumol in Several Diseases; An Overview

    Article • Nutrition and Cancer, April 2020, Taylor & Francis

    Dr MUZAFAR AHMAD MACHA

  6. Exploring Dysregulated Signaling Pathways in Cancer

    Article • Current Pharmaceutical Design, March 2020, Bentham Science Publishers

    Dr MUZAFAR AHMAD MACHA, Ajaz Bhat, Geetanjali Sageena

  7. Claudin-1, A Double-Edged Sword in Cancer

    Article • International Journal of Molecular Sciences, January 2020, MDPI AG

    Dr MUZAFAR AHMAD MACHA

  8. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells

    Article • Journal of Experimental & Clinical Cancer Research, June 2019, Springer Science + Business Media

    Dr MUZAFAR AHMAD MACHA

  9. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer

    Article • EBioMedicine, April 2019, Elsevier

    Dr MUZAFAR AHMAD MACHA

  10. Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity

    Article • JNCI Journal of the National Cancer Institute, January 2019, Oxford University Press (OUP)

    Dr MUZAFAR AHMAD MACHA

  11. Novel therapies hijack the blood–brain barrier to eradicate glioblastoma cancer stem cells

    Article • Carcinogenesis, November 2018, Oxford University Press (OUP)

    Dr MUZAFAR AHMAD MACHA

  12. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, August 2018, Elsevier

    Dr MUZAFAR AHMAD MACHA

  13. Natural products: a hope for glioblastoma patients

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Dr MUZAFAR AHMAD MACHA

  14. Emerging therapeutic potential of graviola and its constituents in cancers

    Article • Carcinogenesis, February 2018, Oxford University Press (OUP)

    Dr MUZAFAR AHMAD MACHA

  15. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells

    Article • Oncotarget, February 2017, Impact Journals, LLC

    Dr MUZAFAR AHMAD MACHA

  16. MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer

    Article • Genes & Cancer, June 2016, Impact Journals, LLC

    Dr MUZAFAR AHMAD MACHA

  17. The canonical Wnt pathway regulates the metastasis‐promoting mucin MUC4 in pancreatic ductal adenocarcinoma

    Article • Molecular Oncology, October 2015, Wiley

    Dr MUZAFAR AHMAD MACHA

  18. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model

    Article • Oncotarget, October 2015, Impact Journals, LLC

    Dr MUZAFAR AHMAD MACHA

  19. Erratum: MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway

    Article • Oncogene, May 2015, Springer Science + Business Media

    Dr MUZAFAR AHMAD MACHA

  20. Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer

    Article • Cancer Treatment Reviews, March 2015, Elsevier

    Dr MUZAFAR AHMAD MACHA

  21. Mucins in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Implications

    Article • Journal of Thoracic Oncology, January 2015, Elsevier

    Dr MUZAFAR AHMAD MACHA

  22. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer

    Article • Advanced Drug Delivery Reviews, January 2015, Elsevier

    Dr MUZAFAR AHMAD MACHA

  23. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma

    Article • International Journal of Clinical Oncology, June 2014, Springer Science + Business Media

    Dr MUZAFAR AHMAD MACHA

  24. MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway

    Article • Oncogene, April 2014, Springer Science + Business Media

    Dr MUZAFAR AHMAD MACHA

  25. MicroRNAs (miRNAs) as Biomarker(s) for Prognosis and Diagnosis of Gastrointestinal (GI) Cancers

    Article • Current Pharmaceutical Design, January 2014, Bentham Science Publishers

    Dr MUZAFAR AHMAD MACHA

  26. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling

    Article • Cancer Letters, December 2013, Elsevier

    Dr MUZAFAR AHMAD MACHA

  27. Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: Potential role in therapy

    Article • Cancer Letters, August 2013, Elsevier

    Dr MUZAFAR AHMAD MACHA

  28. Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma

    Article • Cancer Management and Research, July 2013, Taylor & Francis

    Dr MUZAFAR AHMAD MACHA

  29. Silicon: A Multitalented Micronutrient in OMICS Perspective – An Update

    Article • Current Proteomics, December 2012, Elsevier

    Dr MUZAFAR AHMAD MACHA

  30. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy

    Article • Journal of Hematology & Oncology, October 2012, Springer Science + Business Media

    Dr MUZAFAR AHMAD MACHA

  31. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1

    Article • Carcinogenesis, July 2012, Oxford University Press (OUP)

    Dr MUZAFAR AHMAD MACHA

  32. Identification of proteins secreted by head and neck cancer cell lines using LC‐MS/MS: Strategy for discovery of candidate serological biomarkers

    Article • PROTEOMICS - CLINICAL APPLICATIONS, October 2011, Wiley

    Dr MUZAFAR AHMAD MACHA

  33. Identification of proteins secreted by head and neck cancer cell lines using LC‐MS/MS: Strategy for discovery of candidate serological biomarkers

    Article • PROTEOMICS, May 2011, Wiley

    Dr MUZAFAR AHMAD MACHA

  34. Prognostic significance of nuclear pSTAT3 in oral cancer

    Article • Head & Neck, March 2011, Wiley

    Dr MUZAFAR AHMAD MACHA, Mr Alok Thakar

  35. Guggulsterone Targets Smokeless Tobacco Induced PI3K/Akt Pathway in Head and Neck Cancer Cells

    Article • PLOS One, February 2011, PLOS

    Dr MUZAFAR AHMAD MACHA

  36. Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF- B and STAT3 pathways in head and neck cancer cells

    Article • Carcinogenesis, December 2010, Oxford University Press (OUP)

    Dr MUZAFAR AHMAD MACHA

  37. 14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in Head and Neck cancer cells

    Article • BMC Cancer, November 2010, Springer Science + Business Media

    Dr MUZAFAR AHMAD MACHA

  38. Promoter hypermethylation in Indian primary oral squamous cell carcinoma

    Article • International Journal of Cancer, April 2010, Wiley

    Dr MUZAFAR AHMAD MACHA

  39. Clinical significance of TC21 overexpression in oral cancer

    Article • Journal of Oral Pathology and Medicine, December 2009, Wiley

    Dr MUZAFAR AHMAD MACHA

  40. Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue

    Article • Head & Neck, May 2009, Wiley

    Dr MUZAFAR AHMAD MACHA, Mr Alok Thakar

  41. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients

    Article • International Journal of Cancer, February 2009, Wiley

    Dr MUZAFAR AHMAD MACHA